Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones.
Marchetti A, Milella M, Felicioni L, Cappuzzo F, Irtelli L, Del Grammastro M, Sciarrotta M, Malatesta S, Nuzzo C, Finocchiaro G, Perrucci B, Carlone D, Gelibter AJ, Ceribelli A, Mezzetti A, Iacobelli S, Cognetti F, Buttitta F.
Marchetti A, et al. Among authors: cognetti f.
Neoplasia. 2009 Oct;11(10):1084-92. doi: 10.1593/neo.09814.
Neoplasia. 2009.
PMID: 19794967
Free PMC article.